SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Mimedx Group, Inc. – ‘10-Q’ for 3/31/21 – ‘EX-32.2’

On:  Wednesday, 4/28/21, at 4:14pm ET   ·   For:  3/31/21   ·   Accession #:  1376339-21-32   ·   File #:  1-35887

Previous ‘10-Q’:  ‘10-Q’ on 11/4/20 for 9/30/20   ·   Next:  ‘10-Q’ on 8/3/21 for 6/30/21   ·   Latest:  ‘10-Q’ on 4/30/24 for 3/31/24   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 4/28/21  Mimedx Group, Inc.                10-Q        3/31/21   80:6.8M

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    670K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     22K 
12: R1          Cover                                               HTML     74K 
13: R2          Condensed Consolidated Balance Sheets               HTML    110K 
14: R3          Condensed Consolidated Balance Sheets               HTML     54K 
                (Parenthetical)                                                  
15: R4          Condensed Consolidated Statements of Operations     HTML     92K 
16: R5          Condensed Consolidated Statements of Stockholders'  HTML     71K 
                Deficit                                                          
17: R6          Condensed Consolidated Statements of Cash Flows     HTML    100K 
18: R7          Nature of Business                                  HTML     30K 
19: R8          Significant Accounting Policies                     HTML     60K 
20: R9          Inventory                                           HTML     29K 
21: R10         Property and Equipment                              HTML     37K 
22: R11         Leases                                              HTML    108K 
23: R12         Intangible Assets                                   HTML     58K 
24: R13         Accrued Expenses                                    HTML     33K 
25: R14         Long Term Debt                                      HTML     76K 
26: R15         Net Loss Per Common Share                           HTML     59K 
27: R16         Equity                                              HTML     36K 
28: R17         Income taxes                                        HTML     26K 
29: R18         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     33K 
                Investing and Financing Activities                               
30: R19         Contractual Commitments and Contingencies           HTML     44K 
31: R20         Revenue Data by Customer Type                       HTML     34K 
32: R21         Share-based Compensation                            HTML     55K 
33: R22         Subsequent Events                                   HTML     23K 
34: R23         Significant Accounting Policies (Policies)          HTML     89K 
35: R24         Significant Accounting Policies Significant         HTML     29K 
                Accounting Policies (Tables)                                     
36: R25         Inventory (Tables)                                  HTML     30K 
37: R26         Property and Equipment (Tables)                     HTML     38K 
38: R27         Leases (Tables)                                     HTML     86K 
39: R28         Intangible Assets (Tables)                          HTML     90K 
40: R29         Accrued Expenses (Tables)                           HTML     32K 
41: R30         Long Term Debt (Tables)                             HTML     61K 
42: R31         Net Loss Per Common Share (Tables)                  HTML     59K 
43: R32         Equity Equity (Tables)                              HTML     29K 
44: R33         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     32K 
                Investing and Financing Activities (Tables)                      
45: R34         Revenue Data by Customer Type (Tables)              HTML     29K 
46: R35         Share-based Compensation (Tables)                   HTML     56K 
47: R36         Nature of Business (Details)                        HTML     33K 
48: R37         Significant Accounting Policies - Narrative         HTML     41K 
                (Details)                                                        
49: R38         Significant Accounting Policies - Assessment of     HTML     36K 
                Revenue under ASC 606 (Details)                                  
50: R39         Inventory (Details)                                 HTML     29K 
51: R40         Property and Equipment - Summary of Property and    HTML     40K 
                Equipment (Details)                                              
52: R41         Property and Equipment - Depreciation Expense       HTML     23K 
                (Details)                                                        
53: R42         Leases - Narrative (Details)                        HTML     24K 
54: R43         Leases - Lease Costs (Details)                      HTML     30K 
55: R44         Leases - Supplemental Balance Sheet Information     HTML     48K 
                (Details)                                                        
56: R45         Leases - Maturity of Lease Liabilities (Details)    HTML     85K 
57: R46         Intangible Assets - Activity Summary (Details)      HTML     52K 
58: R47         Intangible Assets - Amortization Expense (Details)  HTML     23K 
59: R48         Intangible Assets - Estimated Future Amortization   HTML     36K 
                Expense for Intangible Assets (Details)                          
60: R49         Accrued Expenses (Details)                          HTML     38K 
61: R50         Long Term Debt - Term Loan (Details)                HTML    107K 
62: R51         Long Term Debt - Term Loan Debt Issuance Costs      HTML     36K 
                (Details)                                                        
63: R52         Long Term Debt - Term Loan Balances (Details)       HTML     35K 
64: R53         Long Term Debt - Term Loan Interest Expense         HTML     41K 
                (Details)                                                        
65: R54         Long Term Debt - Term Loan Maturity (Details)       HTML     38K 
66: R55         Net Loss Per Common Share - Basic Net Loss Per      HTML     50K 
                Common Share (Details)                                           
67: R56         Net Loss Per Common Share - Diluted Net Loss Per    HTML     57K 
                Common Share (Details)                                           
68: R57         Equity - Narrative (Details)                        HTML     63K 
69: R58         Equity - Changes in Series B Preferred Stock        HTML     33K 
                (Details)                                                        
70: R59         Income taxes (Details)                              HTML     34K 
71: R60         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     37K 
                Investing and Financing Activities (Details)                     
72: R61         Contractual Commitments and Contingencies -         HTML     37K 
                Narrative (Details)                                              
73: R62         Revenue Data by Customer Type (Details)             HTML     32K 
74: R63         Share-based Compensation - Narrative (Details)      HTML     25K 
75: R64         Share-based Compensation - Restricted Stock Awards  HTML     59K 
                (Details)                                                        
76: R65         Share-based Compensation - Stock Incentive Plans    HTML     64K 
                (Details)                                                        
78: XML         IDEA XML File -- Filing Summary                      XML    140K 
11: XML         XBRL Instance -- mdxg-20210331_htm                   XML   1.57M 
77: EXCEL       IDEA Workbook of Financial Reports                  XLSX     95K 
 7: EX-101.CAL  XBRL Calculations -- mdxg-20210331_cal               XML    284K 
 8: EX-101.DEF  XBRL Definitions -- mdxg-20210331_def                XML    391K 
 9: EX-101.LAB  XBRL Labels -- mdxg-20210331_lab                     XML   1.49M 
10: EX-101.PRE  XBRL Presentations -- mdxg-20210331_pre              XML    843K 
 6: EX-101.SCH  XBRL Schema -- mdxg-20210331                         XSD    152K 
79: JSON        XBRL Instance as JSON Data -- MetaLinks              350±   502K 
80: ZIP         XBRL Zipped Folder -- 0001376339-21-000032-xbrl      Zip    251K 


‘EX-32.2’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

 Exhibit 32.2
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
    The undersigned Peter M. Carlson, the Chief Financial Officer of MiMedx Group, Inc. (the “Company”), has executed this certification in connection with the filing with the Securities and Exchange Commission of the Company’s Quarterly Report on Form 10-Q for the period ending March 31, 2021 (the “Report”). Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned hereby certifies, to his knowledge, that:

(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:April 28, 2021/s/ Peter M. Carlson
 Peter M. Carlson
 Chief Financial Officer



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:4/28/214,  8-K,  DEFA14A
For Period end:3/31/21
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/27/21  Mimedx Group, Inc.                S-3                    8:2.2M                                   Donnelley … Solutions/FA


3 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/21/21  Mimedx Group, Inc.                8-K:5,9     4/19/21   12:465K                                   Donnelley … Solutions/FA
 3/30/21  Mimedx Group, Inc.                8-K:4,9     3/25/21   13:178K
 3/08/21  Mimedx Group, Inc.                10-K       12/31/20  111:12M
Top
Filing Submission 0001376339-21-000032   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 11:12:26.1pm ET